ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,185
-0,83%
Bitcoin
57 429,16
-5,23%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Mind Medicine MindMed Inc (MNMD)

  7. Mind Medicine MindMed Inc (MNMD) Actualités

MNMD Mind Medicine MindMed Inc

9,30
-0,22 (-2,31%)
Avant marché
Dernière mise à jour : 13:22:17
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Mind Medicine MindMed Inc MNMD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,22 -2,31% 9,30 13:22:17
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,52
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:00BWMindMed to Present at Upcoming May Medical Conferences
02/4/202413:00BWMindMed to Present at Upcoming April Medical Conferences
01/4/202423:00BWMindMed Announces Voluntary Delisting from Cboe Canada
11/3/202413:32EDGAR2Form 8-K - Current report
11/3/202412:00BWMindMed to Participate in the Leerink Partners 2024 Global..
07/3/202414:19EDGAR2Form 8-K - Current report
07/3/202413:13BWMind Medicine (MindMed) Inc. Announces Pricing of..
07/3/202413:09EDGAR2Form S-3MEF - Registration adding securities to prior Form..
07/3/202412:56EDGAR2Form 8-K - Current report
07/3/202412:00BWMindMed Receives FDA Breakthrough Therapy Designation and..
01/3/202419:56EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:00BWMindMed to Host Conference Call and Webcast to Discuss Data..
29/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202413:15EDGAR2Form 8-K - Current report
28/2/202413:05BWMindMed Reports 2023 Financial Results and Business Updates
22/2/202413:00BWMindMed to Host Conference Call and Webcast to Discuss 2023..
07/2/202413:00BWMindMed to Participate in the 34th Annual Oppenheimer..
08/1/202414:00EDGAR2Form 8-K - Current report
08/1/202413:45BWMindMed Announces Business Update and Anticipated Milestones..
26/12/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:24EDGAR2Form 144 - Report of proposed sale of securities
14/12/202313:57EDGAR2Form 8-K - Current report
14/12/202313:30BWMindMed Announces Positive Topline Results from Phase 2b..
02/11/202321:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:15EDGAR2Form 8-K - Current report
02/11/202321:01BWMindMed Reports Third Quarter 2023 Financial Results and..
26/10/202313:30BWMindMed to Host Conference Call and Webcast to Discuss Third..
24/10/202313:30BWMindMed Completes Enrollment of Phase 2a Trial of MM-120 in..
03/10/202313:30BWMindMed to Present Data on the Preclinical Activity of..
26/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202303:02EDGAR2Form 144 - Report of proposed sale of securities
26/9/202303:01EDGAR2Form 144 - Report of proposed sale of securities
26/9/202303:01EDGAR2Form 144 - Report of proposed sale of securities
15/9/202323:27EDGAR2Form 8-K/A - Current report: [Amend]
15/9/202323:23EDGAR2Form 8-K/A - Current report: [Amend]
14/9/202313:30BWMindMed to Participate in the TD Cowen 3rd Annual Novel..
12/9/202313:30BWMindMed Completes Enrollment of Phase 2b Trial of MM-120 in..
29/8/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202316:35EDGAR2Form 144 - Report of proposed sale of securities
28/8/202315:16EDGAR2Form 144 - Report of proposed sale of securities
28/8/202313:30BWMindMed to Participate at September Investor Conferences
14/8/202314:31EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
MNMD
Mind Medicine MindMed
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés